Engineered PD‐L1‐Expressing Platelets Reverse New‐Onset Type 1 Diabetes

Volume: 32, Issue: 26
Published: May 25, 2020
Abstract
The pathogenesis of Type 1 diabetes (T1D) arises from the destruction of insulin‐producing β‐cells by islet‐specific autoreactive T cells. Inhibition of islet‐specific autoreactive T cells to rescue β‐cells is a promising approach to treat new‐onset T1D. The immune checkpoint signal axis programmed death‐1/programmed death‐ligand 1 (PD‐1/PD‐L1) can effectively regulate the activity of T cells and prevent autoimmune attack. Here, megakaryocyte...
Paper Details
Title
Engineered PD‐L1‐Expressing Platelets Reverse New‐Onset Type 1 Diabetes
Published Date
May 25, 2020
Volume
32
Issue
26
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.